Larimar Therapeutics (LRMR) Short Interest Ratio & Short Volume → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free LRMR Stock Alerts $7.38 +0.30 (+4.24%) (As of 04:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Larimar Therapeutics Short Interest DataCurrent Short Interest3,910,000 sharesPrevious Short Interest3,900,000 sharesChange Vs. Previous Month+0.26%Dollar Volume Sold Short$30.77 millionShort Interest Ratio8.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares63,800,000 sharesPercentage of Shares Shorted6.13%Today's Trading Volume422,048 sharesAverage Trading Volume540,357 sharesToday's Volume Vs. Average78% Short Selling Larimar Therapeutics ? Sign up to receive the latest short interest report for Larimar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLRMR Short Interest Over TimeLRMR Days to Cover Over TimeLRMR Percentage of Float Shorted Over Time Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Larimar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,910,000 shares $30.77 million +0.3%N/A8.2 $7.87 4/30/20243,900,000 shares $26.87 million +7.4%N/A6.1 $6.89 4/15/20243,630,000 shares $26.50 million +13.8%N/A5.8 $7.30 3/31/20243,190,000 shares $24.21 million +95.7%N/A5.5 $7.59 3/15/20241,630,000 shares $14.18 million +221.6%N/A2.9 $8.70 2/29/2024506,800 shares $5.83 million -18.0%N/A1.1 $11.50 Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024618,200 shares $8.21 million +82.0%3.5%1.5 $13.28 1/31/2024339,700 shares $1.97 million -4.9%N/A2.2 $5.79 1/15/2024357,100 shares $1.65 million -8.4%N/A2.8 $4.61 12/31/2023390,000 shares $1.77 million -4.0%N/A3 $4.55 12/15/2023406,100 shares $1.71 million -16.5%N/A4.1 $4.22 11/30/2023486,400 shares $1.67 million -7.8%N/A4.6 $3.43 11/15/2023527,400 shares $1.55 million -8.6%N/A4.8 $2.93 10/31/2023576,900 shares $1.69 million +0.2%N/A4.9 $2.93 10/15/2023575,600 shares $1.69 million -11.3%N/A2.7 $2.93 9/30/2023648,700 shares $2.56 million +7.9%N/A3.2 $3.95 9/15/2023601,100 shares $2.55 million -5.1%N/A2.9 $4.24 8/31/2023633,200 shares $2.36 million +9.9%N/A2.3 $3.72 8/15/2023576,200 shares $2.41 million -12.9%N/A2 $4.18 7/31/2023661,800 shares $2.83 million +3.8%N/A1.8 $4.28 7/15/2023637,500 shares $2.05 million +7.3%N/A2.3 $3.21 6/30/2023594,100 shares $1.86 million +296.3%N/A2.1 $3.13 6/15/2023149,900 shares $509,660.00 -23.9%N/A0.5 $3.40 5/31/2023197,000 shares $726,930.00 -12.0%N/A0.8 $3.69 5/15/2023223,800 shares $803,442.00 -14.3%N/A0.8 $3.59 4/30/2023261,000 shares $1.23 million -14.1%N/A1.2 $4.73 4/15/2023303,700 shares $1.38 million -1.2%N/A1.4 $4.53 3/31/2023307,500 shares $1.39 million -12.4%N/A1.5 $4.53 3/15/2023350,900 shares $2.03 million +3.0%N/A2 $5.79 2/28/2023340,600 shares $2.06 million +43.3%N/A1.9 $6.06 2/15/2023237,700 shares $1.41 million -6.2%N/A1.6 $5.93 1/31/2023253,300 shares $1.25 million -0.2%N/A2.2 $4.94 1/15/2023253,900 shares $1.18 million -1.1%N/A2.4 $4.65 12/30/2022256,800 shares $1.06 million -25.4%N/A2.4 $4.13 12/15/2022344,300 shares $1.57 million -9.7%N/A3 $4.56 11/30/2022381,300 shares $1.21 million +2.3%N/A2.2 $3.17 11/15/2022372,800 shares $1.13 million +12.5%N/A2.1 $3.03 10/31/2022331,500 shares $1.09 million +4.5%N/A1 $3.30 10/15/2022317,300 shares $970,938.00 -2.9%N/A1 $3.06 9/30/2022326,700 shares $1.05 million +17.8%N/A1 $3.20Biggest Prediction of My 50-Year Career on Wall Street (Ad)"Bank Runs Will Get Worse," Expert Warns Man who predicted 2023 bank run has warned 8.4 million Americans to get out of U.S. banks immediately. Move your money into a new vehicle 50 years in the making.Click here to learn more. 9/15/2022277,300 shares $934,501.00 +2.0%1.6%0.9 $3.37 8/31/2022271,900 shares $739,568.00 -21.9%1.6%1.2 $2.72 8/15/2022347,900 shares $866,271.00 +93.0%2.0%1.7 $2.49 7/31/2022180,300 shares $322,737.00 -8.9%1.1%5 $1.79 7/15/2022197,900 shares $385,905.00 +4.0%1.2%5.1 $1.95 6/30/2022190,300 shares $372,988.00 -4.4%1.1%5.5 $1.96 6/15/2022199,100 shares $457,930.00 +0.6%1.2%5.8 $2.30 5/31/2022197,900 shares $510,582.00 -33.8%1.2%4.3 $2.58 5/15/2022298,700 shares $761,685.00 -49.0%1.8%4.9 $2.55 4/30/2022585,600 shares $2.17 million -6.9%3.5%2.7 $3.71 4/15/2022628,700 shares $2.22 million -4.1%3.8%3 $3.53 3/31/2022655,300 shares $2.65 million +2.2%3.9%3.1 $4.05 3/15/2022641,100 shares $2.69 million -7.5%3.9%3 $4.20 2/28/2022692,800 shares $3.02 million +66.9%4.2%3.2 $4.36 2/15/2022415,100 shares $1.66 million -0.4%2.5%1.9 $4.01 1/31/2022416,600 shares $4.04 million -20.0%2.5%8.8 $9.70 1/15/2022520,500 shares $4.76 million +16.2%3.1%11.7 $9.15 12/31/2021447,800 shares $4.83 million -9.9%2.7%9.5 $10.79 12/15/2021496,800 shares $4.81 million +1.3%3.0%11.2 $9.68 11/30/2021490,300 shares $4.51 million -4.7%3.0%9.4 $9.19 11/15/2021514,600 shares $5.65 million -2.7%3.1%11.6 $10.98 10/29/2021528,700 shares $6.32 million +3.1%3.3%8.6 $11.95 10/15/2021512,600 shares $6.21 million +3.0%3.2%7.6 $12.12 9/30/2021497,800 shares $5.74 million +10.6%3.1%7 $11.53 9/15/2021450,100 shares $5.60 million -4.9%2.8%3.5 $12.44 8/31/2021473,100 shares $6.81 million -2.6%2.9%3.6 $14.39 8/13/2021485,900 shares $6.48 million +17.2%3.1%2.6 $13.34 7/30/2021414,500 shares $4.12 million -1.2%2.4%1.9 $9.94 7/15/2021419,600 shares $4.37 million -1.8%2.3%1.9 $10.41 6/30/2021427,200 shares $4.20 million +3.3%2.4%1.9 $9.82 6/15/2021413,700 shares $3.32 million -8.4%2.3%2.4 $8.03 5/28/2021451,800 shares $3.75 million +86.9%N/A2.8 $8.31 5/14/2021241,800 shares $2.84 million +14.6%1.7%2.1 $11.76 4/30/2021211,000 shares $2.95 million +30.0%1.4%2.4 $14.00 4/15/2021162,300 shares $2.08 million -47.3%1.2%1.9 $12.84 3/31/2021307,800 shares $4.60 million +12.1%2.2%4.5 $14.93 3/15/2021274,700 shares $4.89 million +10.7%2.0%4.1 $17.79 2/26/2021248,100 shares $4.27 million +9.0%1.8%3.9 $17.20 2/12/2021227,700 shares $4.49 million +1.0%1.6%3.8 $19.71 1/29/2021225,500 shares $3.55 million +11.7%1.6%4.1 $15.75 1/15/2021201,900 shares $4.03 million No Change1.5%4.8 $19.98 LRMR Short Interest - Frequently Asked Questions What is Larimar Therapeutics' current short interest? Short interest is the volume of Larimar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 3,910,000 shares of LRMR short. Learn More on Larimar Therapeutics' current short interest. What is a good short interest ratio for Larimar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LRMR shares currently have a short interest ratio of 8.0. Learn More on Larimar Therapeutics's short interest ratio. Which institutional investors are shorting Larimar Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Larimar Therapeutics: HAP Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Larimar Therapeutics' short interest increasing or decreasing? Larimar Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 3,910,000 shares, an increase of 0.3% from the previous total of 3,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Larimar Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Larimar Therapeutics: Travere Therapeutics, Inc. (17.65%), Astria Therapeutics, Inc. (9.62%), IGM Biosciences, Inc. (24.78%), KalVista Pharmaceuticals, Inc. (13.65%), Entrada Therapeutics, Inc. (9.08%), Heron Therapeutics, Inc. (20.09%), Applied Therapeutics, Inc. (4.00%), Olema Pharmaceuticals, Inc. (15.27%), Oculis Holding AG (0.23%), Fulcrum Therapeutics, Inc. (4.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Larimar Therapeutics stock? Short selling LRMR is an investing strategy that aims to generate trading profit from Larimar Therapeutics as its price is falling. LRMR shares are trading up $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Larimar Therapeutics? A short squeeze for Larimar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LRMR, which in turn drives the price of the stock up even further. How often is Larimar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LRMR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TVTX Short Interest Data ATXS Short Interest Data IGMS Short Interest Data KALV Short Interest Data TRDA Short Interest Data HRTX Short Interest Data APLT Short Interest Data OLMA Short Interest Data OCS Short Interest Data FULC Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LRMR) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsPresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.